8-K/A: Cross Country Healthcare Details CEO Kevin Clark's Compensation

Sentiment:

Executive Compensation Update


Cross Country Healthcare, Inc. filed an amendment to its 8-K report, outlining the comprehensive compensation package for its President and CEO, Kevin C. Clark, including salary, bonuses, and equity awards.

Summary

  • Kevin C. Clark's employment as President and CEO commenced on December 15, 2025, with an initial term of three years, expiring on December 14, 2028, and automatic one-year renewals thereafter.
  • His initial annual base salary is set at $950,000, subject to annual review by the Compensation Committee.
  • For calendar year 2026, Mr. Clark is eligible for an Annual Cash Incentive Program (ACIP) bonus with a target of 100% of his base salary and a maximum of 180%.
  • Beginning in calendar year 2027, his target ACIP bonus will increase to 125% of his base salary, with the maximum remaining at 180%.
  • Mr. Clark is eligible for long-term incentive (LTI) equity awards, with target values of 275% of base salary for 2025, 300% for 2026, and 325% for 2027 and 2028.
  • The agreement includes four weeks of paid vacation, eligibility for senior executive benefit plans, and reimbursement of up to $20,000 (after-tax) for attorney's fees incurred during negotiation.
  • Severance provisions for termination without cause or for good reason include two years of base salary, two times the average ACIP bonus (or a minimum of 50% of target ACIP bonus for the current year), two years of COBRA reimbursements, and accelerated vesting of all unvested equity awards.
  • In the event of company non-renewal, Mr. Clark is entitled to 18 months of base salary.
  • The agreement includes customary restrictive covenants, such as two-year non-competition and non-solicitation clauses, and a perpetual confidentiality covenant.
  • Compensation is subject to any clawback policy adopted by the Board, including those to comply with Section 954 of the Dodd-Frank Act.

Sentiment

Score: 7

Explanation: The filing details a robust and competitive compensation package for the new CEO, which is a positive step in solidifying leadership and aligning executive incentives with company performance. The terms appear standard for a public company CEO, reflecting a well-structured approach to executive retention and motivation.

Positives

  • The employment agreement provides a clear and competitive compensation structure for the new CEO, aligning his incentives with company performance.
  • The comprehensive severance package offers financial security to the CEO, which can attract and retain top talent.
  • The company will reimburse up to $20,000 on an after-tax basis for the CEO's legal fees related to the agreement negotiation, demonstrating a commitment to fair terms.
  • The inclusion of D&O insurance and indemnification provides robust protection for the CEO, consistent with best practices for executive leadership.

Negatives

  • The significant severance package, including two years of base salary and two times the average bonus, represents a substantial financial commitment for the company in the event of an involuntary termination without cause or for good reason.
  • The automatic renewal of the agreement for successive one-year terms could limit flexibility in future executive compensation adjustments without prior notice.

Risks

  • The financial commitment associated with the CEO's compensation package and severance provisions could impact the company's financial flexibility, particularly in adverse economic conditions.
  • The clawback policy, while a governance positive, introduces a risk for the CEO regarding potential forfeiture of compensation if financial statements are inaccurate or underlying information used to calculate compensation is flawed.

Future Outlook

The employment agreement outlines a structured compensation plan for the CEO for several years, including increasing target long-term incentive awards through 2028 and an increased target annual cash incentive bonus starting in 2027. This indicates a clear, forward-looking strategy for executive compensation and performance alignment.

Industry Context

This filing is specific to the compensation of Cross Country Healthcare's CEO and does not provide broader industry trends or competitor analysis. However, the compensation structure, including a mix of base salary, annual cash incentives, and long-term equity awards, is typical for executive packages in the healthcare staffing industry, aiming to attract and retain high-caliber leadership.

Comparison to Industry Standards

  • NA

Management Changes

RolePrevious PersonNew PersonEffective DateReason
President and Chief Executive Officer (CEO)NAKevin C. ClarkDecember 15, 2025Appointment as President and CEO, with this amendment detailing his compensation arrangements.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Executive Compensation PolicyFormalization of President and CEO Kevin C. Clark's employment agreement, including base salary, annual cash incentives, long-term equity incentives, and severance provisions, subject to annual review by the Compensation Committee.January 2, 2026Establishes a clear and competitive compensation structure for the top executive, aligning his interests with long-term company performance and shareholder value, while also incorporating standard protections and restrictive covenants. The inclusion of a clawback policy reinforces accountability.

Stakeholder Impact

  • Shareholders: The detailed compensation structure provides transparency regarding executive pay and aims to align the CEO's incentives with long-term company performance and shareholder value creation.
  • Employees: The CEO's compensation package sets a precedent for executive incentives and overall corporate compensation philosophy, potentially influencing morale and retention strategies for other senior roles.
  • Customers and Suppliers: While not directly impacted, stable and motivated leadership can indirectly benefit these stakeholders through consistent strategic direction and operational efficiency.

Next Steps

  • The Compensation Committee will annually review and consider increasing Mr. Clark's base salary.
  • Mr. Clark will be eligible to participate in the Company's Annual Cash Incentive Program (ACIP) for calendar year 2026 and each year thereafter.
  • Mr. Clark will be eligible to receive equity awards under the Company's long-term incentive plan for each calendar year during the employment term.

Key Dates

DateDescription
2025-12-15Effective date of Kevin C. Clark's employment as President and Chief Executive Officer.
2026-01-02Date the Employment Agreement between Cross Country Healthcare, Inc. and Kevin C. Clark was entered into.
2028-12-14Expiration date of the initial three-year term of the Clark Agreement.

Recommendation

hold

This filing provides specific details on the compensation package for the newly appointed CEO, Kevin C. Clark, which was previously announced. While the terms are comprehensive and competitive, this is a standard follow-up disclosure to an executive appointment and does not introduce new information that would fundamentally alter the company's operational or financial outlook. Investors should continue to hold, awaiting further operational and financial performance updates under the new leadership.

Keywords

Cross Country Healthcare, CCRN, CEO Compensation, Executive Employment Agreement, Kevin C. Clark, SEC Filing, 8-K/A, Healthcare Staffing, Executive Pay, Long-Term Incentive, Annual Bonus, Severance Package, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.